Maliepaard M - Search Results

1

Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line.

Maliepaard M, van Gastelen MA, de Jong LA, Pluim D, van Waardenburg RC, Ruevekamp-Helmers MC, Floot BG, Schellens JH. Maliepaard M, et al. Cancer Res. 1999 Sep 15;59(18):4559-63. Cancer Res. 1999. PMID: 10493507

2

Improved 32P-postlabelling assay for the quantification of the major platinum-DNA adducts.

Welters MJ, Maliepaard M, Jacobs-Bergmans AJ, Baan RA, Schellens JH, Ma J, van der Vijgh WJ, Braakhuis BJ, Fichtinger-Schepman AM. Welters MJ, et al. Among authors: maliepaard m. Carcinogenesis. 1997 Sep;18(9):1767-74. doi: 10.1093/carcin/18.9.1767. Carcinogenesis. 1997. PMID: 9328174 Free article.

3

Abrogated energy-dependent uptake of cisplatin in a cisplatin-resistant subline of the human ovarian cancer cell line IGROV-1.

Ma J, Maliepaard M, Kolker HJ, Verweij J, Schellens JH. Ma J, et al. Among authors: maliepaard m. Cancer Chemother Pharmacol. 1998;41(3):186-92. doi: 10.1007/s002800050727. Cancer Chemother Pharmacol. 1998. PMID: 9443634

4

Cisplatin resistance and DNA repair.

Crul M, Schellens JH, Beijnen JH, Maliepaard M. Crul M, et al. Among authors: maliepaard m. Cancer Treat Rev. 1997 Sep-Nov;23(5-6):341-66. doi: 10.1016/s0305-7372(97)90032-3. Cancer Treat Rev. 1997. PMID: 9465884 Review. No abstract available.

5

Synergistic cytotoxicity of cisplatin and topotecan or SN-38 in a panel of eight solid-tumor cell lines in vitro.

Ma J, Maliepaard M, Nooter K, Boersma AW, Verweij J, Stoter G, Schellens JH. Ma J, et al. Among authors: maliepaard m. Cancer Chemother Pharmacol. 1998;41(4):307-16. doi: 10.1007/s002800050744. Cancer Chemother Pharmacol. 1998. PMID: 9488600

6

Reduced cellular accumulation of topotecan: a novel mechanism of resistance in a human ovarian cancer cell line.

Ma J, Maliepaard M, Nooter K, Loos WJ, Kolker HJ, Verweij J, Stoter G, Schellens JH. Ma J, et al. Among authors: maliepaard m. Br J Cancer. 1998 May;77(10):1645-52. doi: 10.1038/bjc.1998.270. Br J Cancer. 1998. PMID: 9635842 Free PMC article.

7

In vitro antagonistic cytotoxic interactions between platinum drugs and taxanes on bone marrow progenitor cell CFU-GM.

de Graaff M, Maliepaard M, Pluim D, Floot BJ, Slaper-Cortenbach IC, Schellens JH. de Graaff M, et al. Among authors: maliepaard m. Anticancer Drugs. 1999 Feb;10(2):213-8. doi: 10.1097/00001813-199902000-00010. Anticancer Drugs. 1999. PMID: 10211552

8

32P-postlabeling assay for the quantification of the major platinum-DNA adducts.

Pluim D, Maliepaard M, van Waardenburg RC, Beijnen JH, Schellens JH. Pluim D, et al. Among authors: maliepaard m. Anal Biochem. 1999 Nov 1;275(1):30-8. doi: 10.1006/abio.1999.4302. Anal Biochem. 1999. PMID: 10542106

9

Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines.

Scheffer GL, Maliepaard M, Pijnenborg AC, van Gastelen MA, de Jong MC, Schroeijers AB, van der Kolk DM, Allen JD, Ross DD, van der Valk P, Dalton WS, Schellens JH, Scheper RJ. Scheffer GL, et al. Among authors: maliepaard m. Cancer Res. 2000 May 15;60(10):2589-93. Cancer Res. 2000. PMID: 10825126

10

Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan.

Jonker JW, Smit JW, Brinkhuis RF, Maliepaard M, Beijnen JH, Schellens JH, Schinkel AH. Jonker JW, et al. Among authors: maliepaard m. J Natl Cancer Inst. 2000 Oct 18;92(20):1651-6. doi: 10.1093/jnci/92.20.1651. J Natl Cancer Inst. 2000. PMID: 11036110

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters